基于(关键地区、市场参与者、规模和份额)的制药灌装外包市场 - 到 2031 年的预测

  • Report Code : TIPRE00017482
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 158
Buy Now

药品灌装外包市场预计将从 2021 年的 26.5704 亿美元增至 2028 年的 40.1051 亿美元;预计2021年至2028年复合年增长率为6.1%。

制药和生物制药行业为满足填充/完成缺口的需求预计将不断增长以推动市场增长。根据美国食品和药物管理局 (FDA) 药物评价与研究中心 (CDER) 的数据,2020 年批准的新分子实体 (NME) 中生物制剂占 20% 至 29%。 2019年,小分子占所有批准的NME的79%,占FDA批准的48个NME中的38个,生物制剂占批准的48个NME中的10个,占所有NME批准的21%。 2018年,小分子占NME批准的71%,生物制剂占NME批准的29%。内部能力公司有时缺乏制造新产品的能力。这一因素支持了市场的增长。冻干、填充预装注射器和药筒或新型疗法等专业能力需要独特的制造技术,生物技术公司认为从合同制造组织外包是有利的,因为它们具有成本效益。拥有内部无菌灌装和加工能力的公司平均将 39% 的灌装和加工需求外包。

2021 年至 2028 年,北美可能会继续在药品灌装和成品外包市场占据主导地位。美国占据北美市场最大份额,预计在预测期内将继续这一趋势。机器人技术等自动化进步一直是美国灌装/包装作业的进步领域之一。这主要是在很大程度上降低了污染风险,从而有助于区域增长。供应链的整体整合减少了人际互动,正在推动药品灌装和成品外包市场的增长。例如,ABL 于 2017 年在其灌装/包装操作中采用了自动化。该公司在其位于马里兰州罗克维尔的 GMP 生物制造工厂完成了无菌灌装/包装操作的扩展。该公司安装了全自动小瓶灌装系统。这些因素预计将有助于整个药品灌装和成品外包市场的增长。


战略洞察

药品灌装和加工外包市场利润丰厚的区域       

市场洞察

生物制品需求激增

生物药物的不断增加以及对此类治疗干预措施的日益偏好预计将在预测期内推动对药品灌装和成品外包的需求。大约 60% 的灌装/完成服务涉及抗 COVID-19 疫苗的临床和商业规模包装。扩大设施是生物制药公司在大流行期间考虑的关键因素之一。生物制药公司面临着上述变化和预算限制等问题。需要外包来克服这些问题并满足生物制品的需求。合同制造组织对生物制药产品的外包预计将在未来七年推动药品灌装和成品外包行业的发展。约 90% 已安装的灌装/成品产能属于具有商业规模生产能力的市场参与者。超过 85% 的可用灌装和加工产能属于大型公司。

基于成品状态的洞察

根据成品状态,药品灌装和成品外包市场分为固体、半成品和半成品。 -固体和液体。液体细分市场在 2021 年占据最大份额,预计在预测期内将继续保持类似趋势。塑料注射器行业对预充式注射器和小瓶的需求不断增长,预计将推动对药品灌装和成品外包的需求。冻干西林瓶的应用需求正在推动灌装和包装服务市场的增长。此外,全球生物制品制造领域新进入者数量的增加导致外包活动激增。预计这一因素将有助于全球药品灌装和加工外包市场。

药品填充和表面处理外包市场,按成品状态划分 - 2021年和2028年

根据内容,药品灌装和成品外包市场细分为从微生物中分离的有机物质、有机物质从动物和无机物中分离出来。从微生物中分离的有机物质占有相当大的市场份额,预计在预测期内将继续保持类似的趋势。药品灌装和包装外包的进步使得供应链中的污染风险得以成功降低。这种端到端的整合成功满足了对从微生物中分离出的有机物质的需求,从而满足了对药品灌装和成品外包的需求。

在药品灌装和成品外包市场运营的公司采用产品创新战略来满足世界各地不断变化的客户需求,这也使他们能够保持自己的品牌声誉在全球市场上。

药品灌装外包市场

全球药品灌装外包市场根据以下因素进行细分:成品的状态和含量。根据成品状态,市场分为液体、固体和半固体。按内容划分,市场分为从微生物中分离的有机物质、从动物中分离的有机物质和无机物质。按地区划分,全球药品灌装外包市场分为北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。北美市场分为美国、加拿大和墨西哥。欧洲市场分为法国、德国、意大利、西班牙、英国和欧洲其他地区。亚太地区分为中国、日本、韩国、印度、澳大利亚和亚太地区其他地区。中东和非洲分为南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区。南美洲和中美洲分为巴西、阿根廷以及南美洲和中美洲的其他地区。

在该市场运营的公司有 Abbott、TEVA PHARMACEUTICAL INDUSTRIES LTD、Dr. Reddy's Laboratories、Sun Pharmaceutical Industries Ltd、Piramal Enterprises Ltd.、MabPlex International Ltd、WOCKHARDT、 Cytovance Biologics、Thermo Fisher Scientific Inc. (Patheon NV)、勃林格殷格翰国际有限公司等。  

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the pharmaceutical fill and finish outsourcing market?

Biopharmaceutical companies and pharmaceutical companies outsource a portion of the products from the contract outsourcing companies to meet the unmet demand of the companies. This process is termed as the pharmaceutical fill and finish outsourcing.

What are the driving factors for the pharmaceutical fill and finish outsourcing market across the globe?

Rising investment in biopharmaceutical sectors and growing demand for biologics is expected to drive the market

Which segment led the pharmaceutical fill and finish outsourcing market?

Based on content, organic substances isolated from microorganisms took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue a similar trend over the forecast period.

Which application segment held the largest revenue (US$ Mn) in the pharmaceutical fill and finish outsourcing market?

The liquid segment accounted for the largest share in 2021 and is expected to continue during the forecast period.

Who are the key players in the pharmaceutical fill and finish outsourcing market?

Companies operating in the market are Abbott, TEVA PHARMACEUTICAL INDUSTRIES LTD, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd, Piramal Enterprises Ltd., MabPlex International Ltd, WOCKHARDT, Cytovance Biologics, Thermo Fisher Scientific Inc. (Patheon N.V), Boehringer Ingelheim International GmbH amongst others.

What is the regional market scenario of the pharmaceutical fill and finish outsourcing market?

Global pharmaceutical fill and finish outsourcing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the pharmaceutical fill and finish outsourcing market during 2021–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period. Automation advancements such as robotics have been one of the areas of progress for the US fill/finish operations. This primarily reduces the contamination risk to a great extent, thus aiding the regional growth. The overall integration of the supply chain that reduces human interactions is driving the pharmaceutical fill and finish outsourcing market growth.

The List of Companies - Pharmaceutical Fill and Finish Outsourcing Market

  1. Abbott
  2. Teva Pharmaceutical Industries Ltd
  3. Dr. Reddy's Laboratories
  4. Sun Pharmaceutical Industries Ltd
  5. Piramal Enterprises Ltd
  6. MabPlex International Ltd
  7. Wockhardt
  8. Cytovance Biologics
  9. Thermo Fisher Scientific Inc. (Patheon N.V.)
  10. Boehringer Ingelheim International GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports